Sign in
CompletedNo phase

"Right Ventricular Outflow Tract Posterior Septum Pacing" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin

Key facts

Who runs it
Second Affiliated Hospital of Wenzhou Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
109 people enrolled
Started
1 Apr 2023
Ended
1 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Right Ventricular Outflow Tract Posterior Septum Pacing
  • systemic mapping and ablation
Record updated
28 April 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Sign informed consent form
  • Age more than 18 years old
  • Able to understand the purpose of the experiment, voluntarily participate, willing to complete follow-up according to the requirement of the experimental protocol

Who cannot take part

  • Severe cardiopulmonary, liver and kidney dysfunction, and inability to tolerate surgery due to coagulation dysfunction
  • Viral myocarditis, myocardial infarction or stroke with a course of less than six months
  • Simultaneously accompanied by malignant tumours, with an expected lifespan of less than or equal to 1 year
  • Advanced age (more than 90 years old)
  • Severe thoracic deformity
  • Other situations that the researcher deems unsuitable for participation in the study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to make clear that a new method, right ventricular outflow tract (RVOT) posterior septum pacing, has a greater accuracy in predicting the origin of ventricular outflow tract (VOT) ventricular arrhythmias (VAs) compared to the previous electrocardiographic standards for the identification of the origin of ventricular outflow tract. The secondary aim is to investigate, by using the new method, if it can optimize the procedure of radiofrequency catheter ablation.

Read full original descriptionShow less

Researches will break the method of this investigation into two steps:

First step have enrolled 100 patients. This step would be used to compare the results predicted by right ventricular outflow tract posterior septum pacing, with the previously used electrocardiographic criteria and actual target site.

The second step will enroll another 100 patients. In this step, patients will be divided into two groups, one being the new protocol group and the other being the convention group. Patients will also be followed up, for 1 month and 3 months at outpatient clinic post procedure. Procedure time, success rate, fluoroscopy exposure time and complications, are compared between RVOT posterior septum pacing group and convention group.

The 2 groups in the trial

  • Right Ventricular Outflow Tract (RVOT) Posterior Septum Pacing GroupExisting treatment, for comparison

    Treatment: Right Ventricular Outflow Tract Posterior Septum Pacing

  • Convention GroupExisting treatment, for comparison

    Treatment: systemic mapping and ablation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
"Right Ventricular Outflow Tract Posterior Septum Pacing" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin: a Single-center, Prospective, Single Blind, Randomised Controlled Study
Record updated
28 April 2026